Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.
Kush V Bhatt, Joseph Friedman, Lindsay Benster, Rekha Narasimhan, Kevin Yang, Jyoti Mishra, Cory R Weissman, Dhakshin Ramanathan
Community mental health journal April 1, 2026 DOI: 10.1007/s10597-026-01620-x via PubMed
Summary
AI-generated from the abstractRecreational psychedelic use is increasing, but data on adverse events is limited. A retrospective chart review of emergency department visits at UC San Diego Medical Center from 2010 to 2023 identified 232 cases linked to LSD (35%), MDMA (30.2%), and psilocybin (24%). Patients were mostly young, white, and male. Common symptoms included agitation (25.9%) and anxiety (24.6%); 11.2% required psychiatric hospitalization. Factors associated with higher odds of hospitalization were concurrent cannabis use (odds ratio 10.9), history of bipolar disorder (odds ratio 12.67), and history of a primary psychotic disorder (odds ratio 17.10). Most psychedelic-related emergency visits are managed without hospitalization, but these specific vulnerabilities predict severe outcomes.
Study at a glance
| Characteristics | Retrospective chart review Peer reviewed |
|---|---|
| Sample size | 232 |
| Population | Emergency department patients with recreational psychedelic use |
| Keywords | Psychedelic Emergency department Hallucinogen Substance use |
| Key finding | Concurrent cannabis use, history of bipolar disorder, and history of a primary psychotic disorder were associated with increased odds of psychiatric hospitalization among patients with psychedelic-associated emergency visits. |
Abstract
Recreational psychedelic use is increasing, yet data on adverse events remains limited. This study characterized emergency department (ED) visits associated with recreational psychedelic use at UC San Diego Medical Center. We conducted a retrospective chart review of ED encounters (2010–2023). Cases were identified using ICD-10 hallucinogen-related codes and confirmed through manual review. Multivariable logistic regression was employed to identify factors associated with psychiatric hospitalization. We identified 232 cases, primarily related to LSD (35.0%), MDMA (30.2%), and psilocybin (24.0%). The cohort was predominantly young, white, and male. Common psychiatric symptoms included agitation (25.9%) and anxiety (24.6%). Common nonpsychiatric symptoms included nausea/vomiting (9.5%) and diaphoresis (5.2%). 11.2% of cases required psychiatric hospitalization. Factors associated with psychiatric hospitalization included concurrent cannabis use (OR = 10.9, 95% CI 3.37–39.64), history of bipolar disorder (OR = 12.67, 95% CI 2.35–70.43), and history of a primary psychotic disorder (OR = 17.10, 95% CI 2.01–187.49). Psychedelic-associated emergency visits present with various clinical characteristics. While most recreational psychedelic presentations are effectively managed in the emergency department, specific factors predict severe outcomes. Concurrent cannabis use and pre-existing psychotic or bipolar disorders are associated with increased odds of psychiatric hospitalization, underscoring the importance of targeted risk assessment in patients with these vulnerabilities.